Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Plasma leptin levels are related to body composition, sex, insulin levels and the A55V polymorphism of the UCP2 gene

International Journal of Obesity volume 31, pages 1311–1318 (2007)Cite this article

Abstract

Objective:

Circulating leptin levels show a high degree of individual variability even after the main effect of body fatness is accounted for. We therefore wanted to determine the roles of variation in body composition, age, sex and polymorphisms of the UCP2 gene and promoter region on levels of circulating leptin.

Subjects:

One hundred and fifty Caucasian subjects, which represented a cross-section of the population from NE, Scotland, were recruited.

Measurements:

Body composition was measured using dual X-ray absorptiometry. Fasted circulating leptin, insulin, T3 and T4 levels were measured, and all individuals were genotyped for the UCP2 polymorphisms A55V, –866G>A and exon-8 ins/del.

Results:

The results indicate that circulating leptin was significantly related to sex and principle component (PC) scores representing overall adipose tissue mass and a second representing the contrast of central to peripheral bone mineral content. Residual leptin was associated with the A55V polymorphism (P< 0.001) explaining 11.3% of the residual variance. There was a marginal effect associated with exon-8 ins/del (P=0.045) explaining 4.4% of the residual variance in leptin. Loge transformed circulating fasting insulin was related to PC scores representing general adiposity and sex. Residual Loge insulin was associated with the A55V and exon-8 ins/del polymorphisms explaining 5.7% (P=0.015) and 5% (P=0.026) of the residual variation, respectively. The –866G>A polymorphism was not significantly associated with residual leptin or insulin. Leptin and insulin were significantly (P=0.007) correlated. Statistically removing the effect of insulin on leptin still showed association between leptin and A55V (P=0.002). Removing the effect of leptin on insulin, the A55V polymorphism was no longer significant (P=0.120). After accounting for the correlation between insulin and leptin, the exon-8 ins/del was no longer significant for residual leptin (P=0.119) or Loge insulin (P=0.252).

Conclusion:

These data suggest that the A55V polymorphism directly affected the levels of leptin but not via an effect on insulin.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Zhang YY, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM . Positional cloning of the mouse obese gene and its human homolog. Nature 1994; 372: 425–432.

    Article  CAS  Google Scholar 

  2. Flatt PR, Bailey CJ, Kwasowski P, Swanstonflatt SK . Contribution of hyperphagia to the development of metabolic abnormalities in obese hyperglycemic (Ob/Ob) mice. Nutr Rep Int 1989; 40: 1207–1215.

    CAS  Google Scholar 

  3. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540–543.

    Article  CAS  Google Scholar 

  4. Friedman JM, Halaas JL . Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763–770.

    Article  CAS  Google Scholar 

  5. Cone RD . The central melanocortin system and energy homeostasis. Trends Endocrinol Metab 1999; 10: 211–216.

    Article  CAS  Google Scholar 

  6. Ahima RS, Prabakaran D, Mantzoros C, Qu DQ, Lowell B, MaratosFlier E et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250–252.

    Article  CAS  Google Scholar 

  7. Berthoud HR . A new role for leptin as a direct satiety signal from the stomach. Am J Physiol-Regulat Integr Comp Physiol 2005; 288: R796–R797.

    Article  CAS  Google Scholar 

  8. Saladin R, Devos P, Guerremillo M, Leturque A, Girard J, Staels B et al. Transient increase in obese gene-expression after food-intake or insulin administration. Nature 1995; 377: 527–529.

    Article  CAS  Google Scholar 

  9. Ahima RS, Prabakaran D, Flier JS . Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding – implications for energy homeostasis and neuroendocrine function. J Clin Invest 1998; 101: 1020–1027.

    Article  CAS  Google Scholar 

  10. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292–295.

    Article  CAS  Google Scholar 

  11. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81: 3424–3427.

    CAS  Google Scholar 

  12. Ozata M, Ozisik G, Bingol N, Corakci A, Gundogan MA . The effects of thyroid status on plasma leptin levels in women. J Endocrinol Investigat 1998; 21: 337–341.

    Article  CAS  Google Scholar 

  13. Kumar MV, Scarpace PJ . Differential effects of retinoic acid on uncoupling protein-1 and leptin gene expression. J Endocrinol 1998; 157: 237–243.

    Article  CAS  Google Scholar 

  14. Lee KN, Jeong IC, Lee SJ, Oh SH, Cho MY . Regulation of leptin gene expression by insulin and growth hormone in mouse adipocytes. Exp Mol Med 2001; 33: 234–239.

    Article  CAS  Google Scholar 

  15. Tan JTT, Patel BK, Kaplan LM, Koenig JI, Hooi SC . Regulation of leptin expression and secretion by corticosteroids and insulin – implications for body weight. Endocrine 1998; 8: 85–92.

    Article  CAS  Google Scholar 

  16. Rayner DV, Trayhurn P . Regulation of leptin production: sympathetic nervous system interactions. J Mol Med- 2001; 79: 8–20.

    Article  CAS  Google Scholar 

  17. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, Brude IR et al. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 2001; 42: 743–750.

    CAS  PubMed  Google Scholar 

  18. Brann DW, De Sevilla L, Zamorano PL, Mahesh VB . Regulation of leptin gene expression and secretion by steroid hormones. Steroids 1999; 64: 659–663.

    Article  CAS  Google Scholar 

  19. Zhang HH, Kumar S, Barnett AH, Eggo MC . Intrinsic site-specific differences in the expression of leptin in human adipocytes and its autocrine effects on glucose uptake. J Clin Endocrinol Metab 1999; 84: 2550–2556.

    CAS  PubMed  Google Scholar 

  20. Chung WK, Belfi K, Chua M, Wiley J, Mackintosh R, Nicolson M et al. Heterozygosity for Lep(ob) or Lepr(db) affects body composition and leptin homeostasis in adult mice. Am J Physiol-Regulat Integr Compar Physiol 1998; 43: R985–R990.

    Article  Google Scholar 

  21. Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, Trussell R et al. Partial leptin deficiency and human adiposity. Nature 2001; 414: 34–35.

    Article  CAS  Google Scholar 

  22. Butte NF, Hopkinson JM, Nicolson MA . Leptin in human reproduction: serum leptin levels in pregnant and lactating women. J Clin Endocrinol Metab 1997; 82: 585–589.

    Article  CAS  Google Scholar 

  23. Carlsson B, Ankarberg C, Rosberg S, Norjavaara E, AlbertssonWikland K, Carlsson LMS . Serum leptin concentrations in relation to pubertal development. Arch Dis Childhood 1997; 77: 396–400.

    Article  CAS  Google Scholar 

  24. Liu C, Grossmann A, Bain S, Strachan M, Puerner D, Bailey C et al. Leptin stimulates cortical bone formation in obese (ob/ob) mice. J Bone Mineral Res 1997; 12: 50.

    Article  Google Scholar 

  25. Perez C, Fernandez-Galaz C, Fernandez-Agullo T, Arribas C, Andres A, Ros M et al. Leptin impairs insulin signaling in rat adipocytes. Diabetes 2004; 53: 347–353.

    Article  CAS  Google Scholar 

  26. varez-Aguilar C, Mondragon-Jimenez LI, Ramirez-Enriquez J, Gomez-Garcia A, Paniagua-Sierra R, Amato D . Hyperleptinemia as a risk factor in obesity-related hypertension. Med Clin (Barc) 2004; 123: 766–769.

    Article  Google Scholar 

  27. Perusse L, Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G et al. The human obesity gene map: the 2004 update. Obes Res 2005; 13: 381–490.

    Article  CAS  Google Scholar 

  28. Astrup A, Toubro S, Dalgaard LT, Urhammer SA, Sorensen TI, Pedersen O . Impact of the v/v 55 polymorphism of the uncoupling protein 2 gene on 24-h energy expenditure and substrate oxidation. Int J Obes Relat Metab Disord 1999; 23: 1030–1034.

    Article  CAS  Google Scholar 

  29. Klannemark M, Orho M, Groop L . No relationship between identified variants in the uncoupling protein 2 gene and energy expenditure. Eur J Endocrinol 1998; 139: 217–223.

    Article  CAS  Google Scholar 

  30. Yu X, Jacobs Jr DR, Schreiner PJ, Gross MD, Steffes MW, Fornage M . The uncoupling protein 2 Ala55Val polymorphism is associated with diabetes mellitus: the CARDIA study. Clin Chem 2005; 51: 1451–1456.

    Article  CAS  Google Scholar 

  31. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 2001; 28: 178–183.

    Article  CAS  Google Scholar 

  32. D'Adamo M, Perego L, Cardellini M, Marini MA, Frontoni S, Andreozzi F et al. The −866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. Diabetes 2004; 53: 1905–1910.

    Article  CAS  Google Scholar 

  33. Wang H, Chu WS, Lu T, Hasstedt SJ, Kern PA, Elbein SC . Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. Am J Physiol Endocrinol Metab 2004; 286: E1–E7.

    Article  CAS  Google Scholar 

  34. Sesti G, Cardellini M, Marini MA, Frontoni S, D'Adamo M, Del GS et al. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes 2003; 52: 1280–1283.

    Article  CAS  Google Scholar 

  35. Fritsche A, Thart LM, Dekker JM, Machicao F, Heine RJ, Haring HU et al. Variability in insulin secretion in carriers of a common-866G/A polymorphism in the promoter of UCP2 in non-diabetic subjects. Diabetes 2004; 53: A271.

    Google Scholar 

  36. Ji Q, Ikegami H, Fujisawa T, Kawabata Y, Ono M, Nishino M et al. A common polymorphism of uncoupling protein 2 gene is associated with hypertension. J Hypertens 2004; 22: 97–102.

    Article  CAS  Google Scholar 

  37. Johnstone AM, Murison SD, Duncan JS, Rance KA, Speakman JR . Factors influencing variation in basal metabolic rate include fat-free mass, fat mass, age, and circulating thyroxine but not sex, circulating leptin, or triiodothyronine. Am J Clin Nutr 2005; 82: 941–948.

    Article  CAS  Google Scholar 

  38. Marti A, Corbalan S, Forga L, Martinez-Gonzalez MA, Martinez JA . Higher obesity risk associated with the exon-8 insertion of the UCP2 gene in a Spanish case–control study. Nutrition 2004; 20: 498–501.

    Article  CAS  Google Scholar 

  39. Walder K, Norman RA, Hanson RL, Schrauwen P, Neverova M, Jenkinson CP et al. Association between uncoupling protein polymorphisms (UCP2–UCP3) and energy metabolism/obesity in Pima Indians. Hum Mol Genet 1998; 7: 1431–1435.

    Article  CAS  Google Scholar 

  40. Dalgaard LT, Pedersen O . Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type ii diabetes. Diabetologia 2001; 44: 946–965.

    Article  CAS  Google Scholar 

  41. Cassell PG, Neverova M, Janmohamed S, Uwakwe N, Qureshi A, McCarthy MI et al. An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes. Diabetologia 1999; 42: 688–692.

    Article  CAS  Google Scholar 

  42. Ur E, Morash B, Wilkinson M . Nutrient and insulin regulate leptin gene expression in the hypothalamus. Diabetes 2001; 50: A373–A374.

    Google Scholar 

  43. Poitout V, Rouault C, Guerre-Millo M, Reach G . Does leptin regulate insulin secretion? Diabetes Metab 1998; 24: 321–326.

    CAS  Google Scholar 

  44. van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998; 47: 913–917.

    Article  CAS  Google Scholar 

  45. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Internal Med 2004; 140: 992–1000.

    Article  Google Scholar 

  46. Kristensen K, Pedersen SB, Richelsen B . Interactions between sex steroid hormones and leptin in women. Studies in vivo and in vitro. Int J Obes Relat Metab Disord 2000; 24: 1438–1444.

    Article  CAS  Google Scholar 

  47. Langin D . The role of uncoupling protein 2 in the development of type 2 diabetes. Drugs Today 2003; 39: 287–295.

    Article  CAS  Google Scholar 

  48. Maestrini S, Podesta F, Di Blasio AM, Savia G, Brunani A, Tagliaferri A et al. Lack of association between UCP2 gene polymorphisms and obesity phenotype in Italian Caucasians. J Endocrinol Invest 2003; 26: 985–990.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to the Scottish Executive Environment and Rural Affairs Department for funding.

Author information

Authors and Affiliations

  1. Aberdeen Centre for Energy Regulation and Obesity (ACERO), Rowett Research Institute, Bucksburn, Aberdeen, Scotland, UK,

    K A Rance, A M Johnstone, S Murison, J S Duncan, S G Wood & J R Speakman

  2. ACERO, School of Biological Sciences, University of Aberdeen, Aberdeen, Scotland, UK,

    J R Speakman

Authors
  1. K A Rance
    View author publications

    Search author on:PubMed Google Scholar

  2. A M Johnstone
    View author publications

    Search author on:PubMed Google Scholar

  3. S Murison
    View author publications

    Search author on:PubMed Google Scholar

  4. J S Duncan
    View author publications

    Search author on:PubMed Google Scholar

  5. S G Wood
    View author publications

    Search author on:PubMed Google Scholar

  6. J R Speakman
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to K A Rance.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rance, K., Johnstone, A., Murison, S. et al. Plasma leptin levels are related to body composition, sex, insulin levels and the A55V polymorphism of the UCP2 gene. Int J Obes 31, 1311–1318 (2007). https://doi.org/10.1038/sj.ijo.0803535

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803535

Keywords

This article is cited by

Search

Advanced search

Quick links